{{Rsnum
|rsid=555212
|Chromosome=13
|position=113102226
|Orientation=plus
|GMAF=0.2617
|Assembly=GRCh38
|GenomeBuild=38.1
|dbSNPBuild=141
|geno1=(A;A)
|geno2=(A;G)
|geno3=(G;G)
}}{{ population diversity
| geno1=(A;A)
| geno2=(A;G)
| geno3=(G;G)
| CEU | 5.3 | 40.7 | 54.0
| HCB | 20.6 | 50.7 | 28.7
| JPT | 20.4 | 43.4 | 36.3
| YRI | 0.7 | 17.7 | 81.6
| ASW | 1.8 | 24.6 | 73.7
| CHB | 20.6 | 50.7 | 28.7
| CHD | 21.3 | 46.3 | 32.4
| GIH | 2.0 | 22.8 | 75.2
| LWK | 1.8 | 13.6 | 84.5
| MEX | 13.8 | 44.8 | 41.4
| MKK | 0.6 | 9.0 | 90.4
| TSI | 1.0 | 28.4 | 70.6
| HapMapRevision=28
}}{{PMID Auto GWAS
  |PMID=23381943
  |Trait=End-stage coagulation
  |Title=Ischemic stroke is associated with the ABO locus: the EuroCLOT study.
  |RiskAllele=G
  |Pval=1E-15
  |OR=.37
  |ORtxt=[0.28-0.46] unit decrease
  |OA=1
}}

{{PMID Auto
|PMID=20735728
|Title=Haplotype and genotype effects of the F7 gene on circulating factor VII, coagulation activation markers and incident coronary heart disease in UK men.
|OA=1
}}

{{on chip | 23andMe v1}}
{{on chip | 23andMe v2}}
{{on chip | 23andMe v3}}
{{on chip | 23andMe v4}}
{{on chip | FTDNA2}}
{{on chip | HumanOmni1Quad}}
{{on chip | Illumina Human 1M}}